workshop 1- solid tumours
TRANSCRIPT
-
8/2/2019 Workshop 1- Solid Tumours
1/8
Intro/Glossary
Cure
Removal of all cancerous cells from the body. Ideally, the patient will now have the
same life expectancy as someone who doesn't have cancer.
Remission
Reducing the cancer, even to below detectable levels. However, the cancer is not
completely removed, and may return at any time.
Adjuvant chemotherapy
Additional therapy given with the main method of treatment. For example, adjuvant
chemotherapy is chemotherapy given in addition to surgery (the main treatment).
Adjuvant therapy may also include radiation as well. All this is done to decrease the
chances of reoccurrence of cancer
Neo-adjuvant chemotherapy
Chemotherapy given BEFORE the main treatment, for example, chemotherapy may be
carried out to reduce the size of a tumour before surgery, which can reduce the
amount of tissue to cut, reduce the vasculature (that's a good thing, means you'd lose
less blood during surgery) and make it shrink away from healthy tissue to save that
tissue.
NOTE: Remember, chemo is more effective on the outer edge of solid tumours, which
causes the shrinkage.
Palliative chemotherapy
By this point, we know the cancer can't be cured, so chemo is given to reduce thetumour sizes to relieve symptoms. PLUS it can be used to extend life. Just remember,
we can't cure them by this point, make them more comfortable and live a bit longer.
TMN staging system
T= size of the initial tumour, higher the number, bigger it is
N= number of lymph nodes or extent of spread along lymph nodes, higher the number,
it's spread more throughout the lymphatic system
M= indicates if it has metastasized, where 0 is no, 1 is yes.
e.g. T2N1M0 means it's a medium sized tumour with little regional node infiltration and
no distant metastasis.
Metastasis
Bone (leads to bone pain)
Liver (leads to jaundice)
Brain (leads to mental changes)
Lungs (leads to difficulties in breathing)
Cancer cells are able to split off and travel around the body to for new tumours at
different sites of the body. There are four main sites they will go to, leading to a
common set of symptoms:
Disease templates
Breast cancer
The most common cancer in females. However, it does occur rarely in males. The
disease is also more common in older people, which is common for cancers.
Workshop 1- Solid tumours
Oncology Page 1
-
8/2/2019 Workshop 1- Solid Tumours
2/8
Age
Family history
Race
BRCA1 and BRCA2 double strand DNA repair mechanism genes are faulty in a
high number of cases. This mutation can be passed down, leading to somewomen developing breast cancer quite early in life
Early menarche (menstruating from a young age)
Not having children
Increased exposure to estrogen
Pathophysiology is common to most cancers, where the genetic material of cancerous
cells is damaged, leading to unregulated growth. However, there are some specific risk
factors:
Solid, hard
Irregular
Non-tender
Solitary
90% of the time, a small painless lump can be felt
10% of the time, stabbing or aching pain can occur
Sometimes, it can become tender, and a discharge can be seen
Regular screening is recommended
Very, very curable if picked up early
Signs and symptoms:
See above for symptoms if the cancer is advanced.
See common treatment goals
Mastectomy (removal of the breasts)
Note: may be just as effective as mastectomy in some cases
Radiation therapy (instead of surgery)
Non-pharmacological treatments:
Pharmacological treatments (see 'Mechanisms of action' and 'side effects' below for
details):
5-flurouracil
Epirubicin
Cyclophosphamide
Adjuvant therapy with FEC is common:
Notice how the above combo has two drugs which are not specific for any partsof the cell cycle, and 5-FU is specific for the S-phase. This makes them synergistic
as the treatment will work regardless of what stage the cells are in.
Early stage- focus on cure
Paclitaxel
Taxanes
Therefore, avoid use.
CAUTION: anthracyclines have cumulative cardiotoxicity. In other words, if you
used Epirubicin during adjuvant therapy, you can't use it again or anything else in
that family (like doxorubicin).
Late stage- focus on palliative care
Tamoxifen- a estrogen receptor antagonist. Normally, the estrogen
stimulates the growth of the tumour.
Endocrine therapy only if the cancer carries estrogen receptors
Misc
Oncology Page 2
-
8/2/2019 Workshop 1- Solid Tumours
3/8
Trastuzumab AKA Herceptin is only good for HER-2 positive cancers only
Long acting formulation + short acting for breakthrough pain
Also give laxatives to prevent constipation
Opioids like morphine are the gold standard
Paracetamol can work
NSAIDs can be useful for bone pain
Bisphosphonate for bone pain
Pain
Ondansetron plus dexamethasone
Nausea
Non-cancer
Prostate cancer
The most common cancer in males, again it is more common in older people. For
obvious reasons, it cannot occur in females.
Age (old)
Race (African Americans are more affected)
Family history
It has been linked to:
Generally little to no symptoms if locallised
Urgency and dribbling if it's starting to spread (the urethra passes through the
prostate gland, so if it's starting to grow, it will block it, so you can't piss as easily)
Can result in back pain plus other generalised symptoms if advanced
Symptoms are:
Only carry it out if symptoms are present, or if the person has a high risk
PSA assay has a low diagnostic value, some people without cancer have increased
PSA, while people with cancer can have a low PSA
Can confirm cases quite easily and quickly
Digital Rectal Examination (DRE) has good diagnostic value, but people aren't
very keen on having them.
Imaging allows points of interest to be mapped out and biopsied (with a
needle) to check for cancerous cells, helps to grade the cancer.
Transrectal ultrasound
Population wide screening is not implemented, but there are some ways to diagnose
prostate cancer:
Gleason score should be taken, which is where the cancer cells are checked to see if
they form glands (well differentiated cells) or not (undifferentiated cells).
Undifferentiated cells will cause a worse prognosis.
Importantly, we need to know how hormones affect the tumour:
Oncology Page 3
-
8/2/2019 Workshop 1- Solid Tumours
4/8
LH-RH (also known as GnRH or gonadotropin releasing hormone) will stimulate
the pituitary gland to release LH (Lutenizing hormone) and FSH (follicular
stimulating hormone)
LH and FSH will stimulate the testes to release testosterones which will stimulate
the prostate to grow, making the cancer worse
We need to target this pathway for a specific treatment (see below)
Surgery to remove the prostate is well recommended for a complete cure at early
stages (this is the main treatment, and what we're aiming for)
It depends on what side effects the patient prefers
However, radiation is just as effective (external beam therapy, where radiation is
fired at the prostate)
Plus old people are not candidates for this treatment, need to use a
pharmacological treatment
At later stages, surgery to remove the testes (orchidectomy) can be performed
(not very popular though)
Or for some patients, it's better for their life if they just waited and watched the
tumour carefully. This is because these people tend to be old, so it might not be
worth dragging them through treatment to make the rest of their lives miserable.
Non pharmacological treatments:
GnRH agonist, will attempt to over-stimulate the pituitary gland, and cause
the receptors to desensitise to reduce the downstream production of
testosterone
Occurs because at the beginning of treatment, the GnRH receptors
haven't desensitised, so there's a lot of testosterone being produced
downstream
Causes 'tumour flare', which causes an increase in symptoms arising from
the tumour, plus hot flushes, decreased impotence and tender breasts
Goserelin injections- depot of goserelin injected monthly
Non-steroidal testosterone receptor antagonist
Prevents testosterone from binding to the receptor, mainly to counteract
the tumour flare effect
Causes the same side effects as goserelin, but can also cause bone loss
(osteoporosis)
Flutamide tablets- given daily for a short period of time
If non-responsive, need to focus on palliative care and maybe some other
Pharmacological treatments (advanced cancers):
Oncology Page 4
-
8/2/2019 Workshop 1- Solid Tumours
5/8
Surgery is not an option, because it's metastasized
Make sure the chemotherapy agent is compatible with the patient
conventional chemotherapy drugs e.g. vincristine etc.
Colorectal cancer
Very common cancer overall in the population
Age is the main one (again)
Low fibre-high fat diet
Sedentary lifestyle
Hereditary (family history)
Inflammatory bowel conditions (especially Ulcerative colitus, Crohn's disease to a
lesser extent)
Risk factors:
Changes in bowel motions (chronic constipation)
Weight loss
Abdominal pain and cramps
Malaena, tarry stools with blood
Bloating
Signs and symptoms:
Most commonly, a barium enema can be used to check for growths
A colonoscopy may also be used
May be anemic, due to blood loss
A DRE can be used to rule out haemorrhoids as the cause of symptoms
Diagnosis:
Remove the tumour and surrounding tissue to make sure to remove all the
traces of cancer for a total cure
Colostomy will be performed just after the surgery, which is where one
part of the bowel will be open to the outside world to allow food in. Later
on, after the ends have healed, the GI tract is put back together.
Again, surgery is first line treatment for non-metastasized cancers, with adjuvantchemotherapy (FOLFOX)
Adjuvant therapy for local invasion of some tissues
Radiation is more effective for rectal cancers
Radiation is not as effective here
Nutritional support to reverse weight loss
Non-pharmacological treatments:
Folinic acid
5-Flurouracil
Oxaliplatin
FOLFOX (first line treatment):
Capecitabine (prodrug of 5-FU) if not responsive or at late stage
Good for late stage cancers
Bevacizumab is an antibody which prevents the angiogenesis of metastatic
growths, preventing them from growing
Pharmacological treatments:
Common treatment goals
Generally speaking, at earlier stages of cancer, the tumour is small, encapsulated (i.e.
cells are completely surrounded and cannot leave) and has not invaded any other
Oncology Page 5
-
8/2/2019 Workshop 1- Solid Tumours
6/8
tissues. Therefore, a complete cure is possible if the tumour is cut out, with some
adjuvant chemotherapy to make sure there aren't any cancer cells left.
However, in later stages, palliative care is more important, trying to reduce the sizes of
the tumour and distant metastasis. A multitude of drugs can be given, and surgery is
less important because it wouldnt achieve a cure.
Also, we have to weigh up between treating the cancer and preserving the life quality
of the patient. For example, if the person is old and has advanced cancer, then it mightnot be worth giving them chemotherapy because it would severely reduce their life
quality without much of an impact on the life expectancy. See prostate cancer for more
examples.
Mechanisms of action
Specifically targets the S-phase of the cell cycle (because it stops DNA
replication)
Pyridine analogue which gets incorporated into the growing DNA strand.Because it has a fluorine on the 5 position, it stops any more nucleotides
from being added to the molecule, stopping synthesis of DNA.
5-flurouracil
Antimetabolites
Not cell cycle specific
Can trigger apoptosis
Intercalates between bases in DNA to inhibit topoisomerase II and stabilise
topoisomerase II once the DNA has been cut
Cumulative Cardiotoxicity
WARNING: take care with people with ischemic heart disease
Also generates free radicals. However, this is not important to its action,
but it results in some side effects
Doxyrubicin, epirubicin
Anthracyclines
Not cell cycle specific
Can also lead to apoptosis
Binds to nucleophiles, the pyridine bases of DNA, causing alkylation, cross
linking within or between strands of DNA
Causes haemorrhagic cystitis (bleeding in bladder)
Need to co-administer with Mesna and plenty if IV fluids to counter
this
Side product, acrolein, is produced. It causes inflammation of the bladder
Cyclophosphamide
Alkylating agents
Anti-mitotic agent, inhibits microtubule formation by attaching to the actin
subunit
Prevents the M phase (where they build microtubules to split the genetic
material between nuclei)
Paclitaxel
Taxanes
Also prevents mitosis by inhibiting microtubule formation by attaching to
the actin subunit
Attaches at a different site compared to taxanes
VincristineVinca alkaloids
Oncology Page 6
-
8/2/2019 Workshop 1- Solid Tumours
7/8
Prevents the M phase
Binds to DNA (crosslinking between strands)
DNA becomes unusable
Oxaliplatin
Platins
Serotonin 5-HT3 receptor antagonist
Antiemetic effect
Ondansetron
Glucocorticoid
Enhances the effect of Ondansetron
Dexamethasone
Non-cancer agents
Side effects
General side effects and how to avoid them:
Fluid from infusion can seep out into surrounding tissues
Incredibly dangerous as some drugs are vesicants (blistering agents)
May be caused by poor circulation (due to incorrect line site, use a central
line, which has good flow compared to a peripheral line)
Patients must be told to report discomfort or pain at the infusion site so it
can be stopped and an antidote can be administered.
Extravasation (immediate effect)
Caused when the drug is detected by the chemoreceptor zone in the brain,
triggers nausea and vomiting
Ondensetron and Dexamethasone are commonly used
Nausea and vomiting (immediate effect)
Will also damage oral linings as well as the rest of the GI tract, leading to
diarrhoea
Occurs because the mucus membranes contain rapidly dividing cells, and
they too are affected by treatment
Good oral health and nystatin (anti-fungal drug) are given to prevent oral
issues, while loperamide (anti-diarrhoeal) will be given for GI symptoms.
Mucositis and diarrhoea (delayed effect)
Reduced white blood cells and platelets, leading to increased bleeding or
susceptibility to infections
Again, the bone marrow contains rapidly dividing cells, leading to a
shortage in these cells
Worst suppression occurs 7-14 days after infusion
Need to monitor blood cell counts weekly
If neutrophils are very low, they must be put into isolation
gCSF (granulocyte Colony-Stimulating Factor) can be given to stimulate
white blood cells to grow
Sore throat
Pain on urination
Feeling pretty shit
But NO fever is present
WARNING: must tell patients to look for symptoms of infection:
Myelosuppression/neutropenia (delayed effect)
Oncology Page 7
-
8/2/2019 Workshop 1- Solid Tumours
8/8
Again due to hair follicles containing rapidly dividing cells
Use a government subsidised wig or just buy a scarf
Hair loss and alopecia (delayed effect)
Specific side effects have been listed with the specific drug